Racepoint Global’s Washington D.C. Office Names Matthew Bennett SVP

September 24, 2014

BOSTON, September 24, 2014Racepoint Global, an integrated marketing communications agency at the intersection of influence and action today announced the hire of Matt Bennett as senior vice president.

An expert in healthcare and technology policy and communications, Bennett will lead Racepoint’s Washington, D.C. office and will oversee campaigns that include brand creation and alignment, public affairs, as well as digital and strategy development for the agency’s technology and healthcare clients.

“I am thrilled to join Racepoint at this fascinating moment in communications, advocacy and engagement,” said Matt Bennett.  “The combination of dynamic policy issues, communications technologies that evolve by the minute and disruptions in every marketplace create new opportunities and challenges for communicators. I look forward to helping Racepoint’s clients thrive and connect with their audiences in this exciting environment.”

Before joining Racepoint Global, Bennett was the SVP of Communications & Public Affairs for the Pharmaceutical Research and Manufacturers Association (PhRMA). Prior to this position, Bennett was a Senior Vice President for GolinHarris, leading the firm’s D.C. health group.  He was the senior subject matter expert for all of the global firms’ offices, and provided counsel on health care reform, Medicare, and FDA issues, among others.

“Racepoint Global has leveraged its expertise in social to expand and radically improve the way organizations engage key constituent groups and manage their public affairs campaigns,” said Racepoint Global president, Peter Prodromou.  “Organizations facing major regulatory change in the technology, health and life sciences sectors have come to trust our brand of public affairs as central to their goals.  With the addition of Matt Bennett, we have strengthened our leadership and deepened our expertise in a way that will enable us to foster more growth and meet increasing demand for our breakthrough work.”